These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
144 related articles for article (PubMed ID: 9138070)
21. Inhibition of bioprosthesis calcification due to synergistic effect of Fe/Mg ions to polyethylene glycol grafted bovine pericardium. Vasudev SC; Chandy T; Umasankar MM; Sharma CP J Biomater Appl; 2001 Oct; 16(2):93-107. PubMed ID: 11794726 [TBL] [Abstract][Full Text] [Related]
22. Heparinized bovine pericardium as a novel cardiovascular bioprosthesis. Lee WK; Park KD; Han DK; Suh H; Park JC; Kim YH Biomaterials; 2000 Nov; 21(22):2323-30. PubMed ID: 11026639 [TBL] [Abstract][Full Text] [Related]
23. Diamine-extended glutaraldehyde- and carbodiimide crosslinks act synergistically in mitigating bioprosthetic aortic wall calcification. Zilla P; Bezuidenhout D; Torrianni M; Hendriks M; Human P J Heart Valve Dis; 2005 Jul; 14(4):538-45. PubMed ID: 16116882 [TBL] [Abstract][Full Text] [Related]
24. Triglycidylamine crosslinking of porcine aortic valve cusps or bovine pericardium results in improved biocompatibility, biomechanics, and calcification resistance: chemical and biological mechanisms. Connolly JM; Alferiev I; Clark-Gruel JN; Eidelman N; Sacks M; Palmatory E; Kronsteiner A; Defelice S; Xu J; Ohri R; Narula N; Vyavahare N; Levy RJ Am J Pathol; 2005 Jan; 166(1):1-13. PubMed ID: 15631995 [TBL] [Abstract][Full Text] [Related]
25. Polyethylene glycol (PEG) modified bovine pericardium as a biomaterial: a comparative study on immunogenicity. Aravind S; Paul W; Vasudev SC; Sharma CP J Biomater Appl; 1998 Oct; 13(2):158-65. PubMed ID: 9777465 [TBL] [Abstract][Full Text] [Related]
26. Effect of pretreatment with epoxy compounds on the mechanical properties of bovine pericardial bioprosthetic materials. Xi T; Liu F; Xi B J Biomater Appl; 1992 Jul; 7(1):61-75. PubMed ID: 1432579 [TBL] [Abstract][Full Text] [Related]
27. In vivo biomechanical assessment of triglycidylamine crosslinked pericardium. Sacks MS; Hamamoto H; Connolly JM; Gorman RC; Gorman JH; Levy RJ Biomaterials; 2007 Dec; 28(35):5390-8. PubMed ID: 17822757 [TBL] [Abstract][Full Text] [Related]
28. Shrinkage temperature and anti-calcification property of triglycidylamine-crosslinked autologous tissue. Sato M; Hiramatsu Y; Matsushita S; Sato S; Watanabe Y; Sakakibara Y J Artif Organs; 2014 Sep; 17(3):265-71. PubMed ID: 24794331 [TBL] [Abstract][Full Text] [Related]
29. Effects of glutaraldehyde concentration and fixation time on material characteristics and calcification of bovine pericardium: implications for the optimal method of fixation of autologous pericardium used for cardiovascular surgery. Lee C; Lim HG; Lee CH; Kim YJ Interact Cardiovasc Thorac Surg; 2017 Mar; 24(3):402-406. PubMed ID: 28011740 [TBL] [Abstract][Full Text] [Related]
30. New treatments using alginate in order to reduce the calcification of bovine bioprosthetic heart valve tissue. Shanthi C; Rao KP J Biomater Sci Polym Ed; 1997; 8(12):919-30. PubMed ID: 9399142 [TBL] [Abstract][Full Text] [Related]
31. A novel anti-calcification strategy of bovine pericardium using sodium bisulfite modification. Zhou J; Jiang H; Wang D; Hu S J Heart Valve Dis; 2009 Mar; 18(2):180-5; discussion 186. PubMed ID: 19455893 [TBL] [Abstract][Full Text] [Related]
32. A novel chemical modification of bioprosthetic tissues using L-arginine. Jee KS; Kim YS; Park KD; Kim YH Biomaterials; 2003 Sep; 24(20):3409-16. PubMed ID: 12809769 [TBL] [Abstract][Full Text] [Related]
33. Mechanical loading of bovine pericardium accelerates enzymatic degradation. Ellsmere JC; Khanna RA; Lee JM Biomaterials; 1999 Jun; 20(12):1143-50. PubMed ID: 10382830 [TBL] [Abstract][Full Text] [Related]
34. Transplantation material bovine pericardium: biomechanical and immunogenic characteristics after decellularization vs. glutaraldehyde-fixing. Hülsmann J; Grün K; El Amouri S; Barth M; Hornung K; Holzfuß C; Lichtenberg A; Akhyari P Xenotransplantation; 2012; 19(5):286-97. PubMed ID: 22978462 [TBL] [Abstract][Full Text] [Related]
35. Biocompatibility study of a biological tissue fixed with a naturally occurring crosslinking reagent. Huang LL; Sung HW; Tsai CC; Huang DM J Biomed Mater Res; 1998 Dec; 42(4):568-76. PubMed ID: 9827681 [TBL] [Abstract][Full Text] [Related]
36. Modification of human pericardium by chemical crosslinking. Filová E; Staňková L; Eckhardt A; Svobodová J; Musílková J; Pala J; Hadraba D; Brynda E; Koňařík M; Pirk J; Bačáková L Physiol Res; 2020 Feb; 69(1):49-59. PubMed ID: 31852209 [TBL] [Abstract][Full Text] [Related]
37. Cytotoxicity of PVPAC-treated bovine pericardium: a potential replacement for glutaraldehyde in biological heart valves. Barros JA; Filippin-Monteiro FB; de Oliveira EM; Campa A; Catalani LH; Pitombo Rde N; Polakiewicz B J Biomed Mater Res B Appl Biomater; 2014 Apr; 102(3):574-82. PubMed ID: 24123957 [TBL] [Abstract][Full Text] [Related]
38. Lyophilized bovine pericardium treated with a phenethylamine-diepoxide as an alternative to preventing calcification of cardiovascular bioprosthesis: preliminary calcification results. Aimoli CG; Nogueira GM; Nascimento LS; Baceti A; Leirner AA; Maizato MJ; Higa OZ; Polakiewicz B; Pitombo RN; Beppu MM Artif Organs; 2007 Apr; 31(4):278-83. PubMed ID: 17437496 [TBL] [Abstract][Full Text] [Related]